Preface on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care1
Lung cancer diagnostics and treatments 2015: a renaissance of patient care
Translational Lung Cancer Research
2015;
4
(5)
:501-502
.
(28 October 2015)
Review Article on Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care1
Lung cancer biomarkers, targeted therapies and clinical assays
Translational Lung Cancer Research
2015;
4
(5)
:503-514
.
(28 October 2015)
Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
Translational Lung Cancer Research
2015;
4
(5)
:515-523
.
(28 October 2015)
Treatment of advanced squamous cell carcinoma of the lung: a review
Translational Lung Cancer Research
2015;
4
(5)
:524-532
.
(28 October 2015)
Novel therapies in small cell lung cancer
Translational Lung Cancer Research
2015;
4
(5)
:533-544
.
(28 October 2015)
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies
Translational Lung Cancer Research
2015;
4
(5)
:545-552
.
(28 October 2015)
New strategies in immunotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2015;
4
(5)
:553-559
.
(28 October 2015)
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
Translational Lung Cancer Research
2015;
4
(5)
:560-575
.
(28 October 2015)
Management of hyperglycemia from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeting T790M-mediated resistance
Translational Lung Cancer Research
2015;
4
(5)
:576-583
.
(28 October 2015)
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer
Translational Lung Cancer Research
2015;
4
(5)
:584-597
.
(28 October 2015)
Original Article
Diagnostic and therapeutic value of computed tomography guided coil placement after digital subtraction angiography guided video-assisted thoracoscopic surgery resection for solitary pulmonary nodules
Translational Lung Cancer Research
2015;
4
(5)
:598-604
.
(28 October 2015)
Interlobar fixation using TachoSil®: a novel technique
Translational Lung Cancer Research
2015;
4
(5)
:605-609
.
(28 October 2015)
Evidence-Based Medicine2
Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis
Translational Lung Cancer Research
2015;
4
(5)
:610-618
.
(28 October 2015)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)3
Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Translational Lung Cancer Research
2015;
4
(5)
:619-622
.
(28 October 2015)
Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Translational Lung Cancer Research
2015;
4
(5)
:623-626
.
(28 October 2015)
Rebuttal from Ms Woodford and Dr Senthi
Translational Lung Cancer Research
2015;
4
(5)
:627-628
.
(28 October 2015)
Rebuttal from Dr Nestle and Dr Belderbos
Translational Lung Cancer Research
2015;
4
(5)
:629
.
(28 October 2015)
Editorial
Patient-centered care in lung cancer: exploring the next milestones
Translational Lung Cancer Research
2015;
4
(5)
:630-634
.
(28 October 2015)
Maintenance sunitinib for extensive-stage small cell lung cancer: a new standard, an option or a step in the right direction?
Translational Lung Cancer Research
2015;
4
(5)
:635-638
.
(28 October 2015)
Crizotinib as first line therapy for advanced ALK-positive non-small cell lung cancers
Translational Lung Cancer Research
2015;
4
(5)
:639-641
.
(28 October 2015)
PROFILE 1014: lessons for the new era of lung cancer clinical research
Translational Lung Cancer Research
2015;
4
(5)
:642-648
.
(28 October 2015)
Moving molecularly directed therapies to the first-line in ALK-positive lung cancer: crizotinib is just the beginning
Translational Lung Cancer Research
2015;
4
(5)
:649-652
.
(28 October 2015)
Customizing chemotherapy in non-small cell lung cancer: the promise is still unmet
Translational Lung Cancer Research
2015;
4
(5)
:653-655
.
(28 October 2015)
What do we know about ground-glass opacity nodules in the lung?
Translational Lung Cancer Research
2015;
4
(5)
:656-659
.
(28 October 2015)
Revisiting the role of COX-2 inhibitor for non-small cell lung cancer
Translational Lung Cancer Research
2015;
4
(5)
:660-664
.
(28 October 2015)
Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?
Translational Lung Cancer Research
2015;
4
(5)
:665-666
.
(28 October 2015)
Letter to the Editor
Response to “Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?”
Translational Lung Cancer Research
2015;
4
(5)
:667
.
(28 October 2015)
News
Congratulations to TLCR’s Honorary Editor-in-Chief, Editorial Board Member and Author for winning three IASLC distinguished awards
Translational Lung Cancer Research
2015;
4
(5)
:668-671
.
(28 October 2015)
Stories behind a precious photo
Translational Lung Cancer Research
2015;
4
(5)
:672-674
.
(28 October 2015)
Disclosure:
1. The series “Lung Cancer Diagnostics and Treatments 2015: A Renaissance of Patient Care” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Edward S. Kim served as the unpaid Guest Editor for the series.
2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
3. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.